We further analyzed the correlation between ACE2 expression and the above immune markers in cancers, including KIRC, PAAD and PRAD, through GEPIA (Table 2), the results were similar to those in TIMER; meanwhile, we found significant correlations in normal tissues (from both TCGA and GTEx). Here, ACE2 is linked to pancreatic adenocarcinoma.